A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 4, 2011, Pages 349-355

  Kliment, Corrine R ^a   Englert, Judson M ^a   Crum, Lauren P ^a   Oury, Tim D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Asbestos; Collagen quantification; Hydroxyproline; Pulmonary fibrosis; Sirius red

Indexed keywords

AZO COMPOUND; BIOLOGICAL MARKER; C.I. DIRECT RED 80; COLLAGEN; COLORING AGENT; CROCIDOLITE; HYDROXYPROLINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; ASBESTOSIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COLORIMETRY; DISEASE MODEL; HOSPITALIZATION; LUNG; LUNG FIBROSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; REPRODUCIBILITY; SPECTROPHOTOMETRY; STANDARD; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ASBESTOS, CROCIDOLITE; ASBESTOSIS; AZO COMPOUNDS; BIOLOGICAL MARKERS; COLLAGEN; COLORIMETRY; COLORING AGENTS; DISEASE MODELS, ANIMAL; HYDROXYPROLINE; LUNG; MALE; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; UP-REGULATION;

EID: 80051617064     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Last JA and Reiser KM. Collagen biosynthesis. Environ Health Perspect 1984; 55: 169-177.
2. Woessner JF, Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-447.
3. Lazo JS, Hoyt DG, Sebti SM and Pitt BR. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther 1990; 47: 347-358.
4. Fattman CL, Chang LY, Termin TA, Petersen L, Enghild JJ and Oury TD. Enhanced bleomycininduced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 2003; 35: 763-771.
5. Fattman C CC, Oury, TD.. Experimental Models of Asbestos-Related Diseases. In: Roggli V, Oury, TD, Sporn, TA., editors. Pathology of Asbestos-Associated Diseases. New York: Springer-Verlag; 2005. p. 256-308.
6. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP and Martinez FJ. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-1727.
7. Gross TJ and Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517-525.
8. Jackson DS and Bentley JP. On the significance of the extractable collagens. J Biophys Biochem Cytol 1960; 7: 37-42.
9. Neuman RE and Logan MA. The determination of hydroxyproline. J Biol Chem 1950; 184: 299-306.
10. Junqueira LC, Bignolas G and Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-455.
11. Whittaker P, Kloner RA, Boughner DR and Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 1994; 89: 397-410.
12. Tullberg-Reinert H and Jundt G. In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol 1999; 112: 271-276.
13. Walsh BJ, Thornton SC, Penny R and Breit SN. Microplate reader-based quantitation of collagens. Anal Biochem 1992; 203: 187-190.
14. James J, Bosch KS, Aronson DC and Houtkooper JM. Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 1990; 10: 1-5.
15. Tan RJ, Fattman CL, Watkins SC and Oury TD. Redistribution of pulmonary EC-SOD after exposure to asbestos. J Appl Physiol 2004; 97: 2006-2013.
16. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, Kasper M, Bierhaus A and Oury TD. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172: 583-591.
17. Kliment CR, Englert JM, Gochuico BR, Yu G, Kaminski N, Rosas IO and Oury TD. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 2008;
18. Oury TD, Thakker K, Menache M, Chang LY, Crapo JD and Day BJ. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol 2001; 25: 164-169.
19. Myllarniemi M, Lindholm P, Ryynanen MJ, Kliment CR, Salmenkivi K, Keski-Oja J, Kinnula VL, Oury TD and Koli K. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: 321-329.